741 related articles for article (PubMed ID: 21465481)
21. Plasminogen activator inhibitor-1 and diabetic nephropathy.
Lee HB; Ha H
Nephrology (Carlton); 2005 Oct; 10 Suppl():S11-3. PubMed ID: 16174279
[TBL] [Abstract][Full Text] [Related]
22. Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts.
Wu Y; Zhang Q; Ann DK; Akhondzadeh A; Duong HS; Messadi DV; Le AD
Am J Physiol Cell Physiol; 2004 Apr; 286(4):C905-12. PubMed ID: 14644771
[TBL] [Abstract][Full Text] [Related]
23. Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells.
Song CY; Kim BC; Hong HK; Kim BK; Kim YS; Lee HS
Am J Physiol Renal Physiol; 2002 Sep; 283(3):F423-30. PubMed ID: 12167592
[TBL] [Abstract][Full Text] [Related]
24. uPA binding to PAI-1 induces corneal myofibroblast differentiation on vitronectin.
Wang L; Ly CM; Ko CY; Meyers EE; Lawrence DA; Bernstein AM
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4765-75. PubMed ID: 22700714
[TBL] [Abstract][Full Text] [Related]
25. Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition.
Ghosh AK; Bradham WS; Gleaves LA; De Taeye B; Murphy SB; Covington JW; Vaughan DE
Circulation; 2010 Sep; 122(12):1200-9. PubMed ID: 20823384
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.
Moriwaki H; Stempien-Otero A; Kremen M; Cozen AE; Dichek DA
Circ Res; 2004 Sep; 95(6):637-44. PubMed ID: 15297377
[TBL] [Abstract][Full Text] [Related]
27. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
28. Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice.
Molinas CR; Elkelani O; Campo R; Luttun A; Carmeliet P; Koninckx PR
Fertil Steril; 2003 Jul; 80(1):184-92. PubMed ID: 12849822
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 by grape seed proanthocyanidin extract.
Sandra D; Radha M; Harishkumar M; Yuichi N; Sayuri O; Masugi M
Phytomedicine; 2010 Jan; 17(1):42-6. PubMed ID: 19640694
[TBL] [Abstract][Full Text] [Related]
30. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures.
Tuan TL; Wu H; Huang EY; Chong SS; Laug W; Messadi D; Kelly P; Le A
Am J Pathol; 2003 May; 162(5):1579-89. PubMed ID: 12707042
[TBL] [Abstract][Full Text] [Related]
31. Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts.
Zhong J; Yang HC; Kon V; Fogo AB; Lawrence DA; Ma J
Lab Invest; 2014 Jun; 94(6):633-44. PubMed ID: 24687120
[TBL] [Abstract][Full Text] [Related]
32. [Changes of u-PA and PAI-1 expression in the lung tissue of neonatal rats after inhaling high concentration oxygen].
Liu XY; Xue XD
Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):458-63. PubMed ID: 19099788
[TBL] [Abstract][Full Text] [Related]
33. Temporal expression of urokinase type plasminogen activator, tissue type plasminogen activator, plasminogen activator inhibitor type 1 in rhesus monkey corpus luteum during the luteal maintenance and regression.
Liu K; Liu YX; Hu ZY; Zou RY; Chen YJ; Mu XM; Ny T
Mol Cell Endocrinol; 1997 Oct; 133(2):109-16. PubMed ID: 9406856
[TBL] [Abstract][Full Text] [Related]
34. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.
Liu RM
Antioxid Redox Signal; 2008 Feb; 10(2):303-19. PubMed ID: 17979497
[TBL] [Abstract][Full Text] [Related]
36. Progress of tissue injury in appendicitis involves the serine proteases uPA and PAI-1.
Solberg A; Holmdahl L; Falk P; Willén R; Palmgren I; Ivarsson ML
Scand J Gastroenterol; 2009; 44(5):579-84. PubMed ID: 19153874
[TBL] [Abstract][Full Text] [Related]
37. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
[TBL] [Abstract][Full Text] [Related]
38. Role of plasminogen activator inhibitor - 1 (PAI-1) in regulating the pathogenesis of S. aureus arthritis via plasminogen pathway.
Sultana S; Dey R; Bishayi B
Immunol Lett; 2019 May; 209():53-66. PubMed ID: 30922783
[TBL] [Abstract][Full Text] [Related]
39. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
[TBL] [Abstract][Full Text] [Related]
40. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
Hu ZY; Liu YX; Liu K; Byrne S; Ny T; Feng Q; Ockleford CD
J Anat; 1999 Feb; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
